On Pharma Trends and Big Company Innovation
Listen now
Description
with @vasnarasimhan @jorgecondebio @vijaypande @smc90 How does the world’s largest producer of medicines in terms of volume balance the science and  the business of innovation, from R&D to go to market to talent and more?
More Episodes
Over 3,700 companies applied to a16z’s SPEEDRUN. In this episode, we meet the founders pushing the boundaries of what games can be. From the fusion of traditional gaming elements with modern tech-twists, a16z General Partner Andrew Chen and Partner Josh Lu discuss the challenges and wins of...
Published 04/26/24
Published 04/26/24
Senator Todd Young (R-IN) speaks with a16z General Partner Martin Casado about the importance of open innovation and American leadership in AI, and why we need to support AI research at all levels — from the classroom to the war room. In this episode, we distinguish science fiction from science...
Published 04/22/24